CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

REGISTER INTEREST FOR OXON’s FREE LIVE ONLINE REAL WORLD MASTERCLASS SERIES 2022-2023

OXON Masterclasses

OUR FREE LIVE REAL WORLD MASTERCLASS SERIES WILL BE BACK AFTER THE SUMMER

‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’

Dates: Restarting in September 2023 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST

OXON will be resuming the series of masterclasses on real world evidence after the summer

This Masterclass series follows the successful Masterclasses in 2021on real-world studies and RCTs by OXON and the eminent statistician, Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (devised: ‘Pocock Stopping Rule’, ‘Win Ratio’. ‘Individualising benefit-risk’); extensive experience with EMA/FDA and data monitoring committees (including adaptive platform Covid-19 DISCOVERY trial); >500 publications (100+ NEJM/Lancets) mainly of trials and epidemiology.

The series provides practical knowledge and advice from national academic experts to apply to field, secondary data and hybrid observational studies for safety, HEOR/market access and clinical development. It is aimed at professionals in the biopharmaceutical and medical device industries, anywhere in the world, involved in the production of real-world evidence and conduct of observational studies in Europe and Asia.

UPCOMING MASTERCLASSES CALENDAR

Convert to my timezone

TitleDateStart TimeDurationRegister
Free Live Masterclass Series on RW Studies. Session 11 OXON’s Free Live Real-World Masterclass Series
"xxxxx"
Date: Wednesday, 14 June 2023 at 5pm CEST | 4pm BST | 11am EDT | 8am PST

Keynote Speaker: Prof

An understanding of the health care system in the xxxx and how medicine is practised within its context.
In 60 minutes, get practical knowledge and advice to apply to your next field, secondary data or hybrid observational study for safety, HEOR/market access, drug development and marketing.

Topics include:

-Key demographic profile relevant to health care
-Structure of healthcare
-Clinical practice patterns
-Data sources, their strengths and challenges
-Strengths and challenges for field studies and use of innovative methodologies
-Q&A session

CHAIR: Nawab Qizilbash MRCP(UK) MSc DPhil(Oxon)
Senior Clinical Epidemiologist, OXON
Hon. Associate Professor, London School of Hygiene and Tropical Medicine
Clinical Observer, Madrid and Formerly Hon. Consultant Physician, Oxford

KEY SPEAKER: Prof Morten Andersen
Professor in Pharmacovigilance and Translational Pharmacology at the University of Copenhagen, Head of the Pharmacovigilance Research Center and Member of the WHO International Working Group for Drug Statistics Methodology.

Webinar ID
428-954-643

Details:
- We will be using GoToWebinar.
- You can join our session by using a Mac, PC or a mobile device.
- You will receive a confirmation email. Use the link to join the session, or login at https://global.gotowebinar.com/join and enter the 9-digit Webinar ID and the email address you used to register.

Please start registering by entering your data.
14 Jun, 202317:00 CEST1 hour
Register

About OXON’s Free Live Masterclass Series on RW Studies

These are masterclass sessions to understand the healthcare for RW studies, led by leading professors of pharmacoepidemiology in Europe and Asia, centred on the practical theme of  “How to ensure success of your RWE studies and avoid pitfalls”

The series are delivered by leading native pharmacoepidemiologists together with OXON, and are centred on understanding healthcare and data sources to fulfil RW field and secondary data studies in their various countries.

The remaining sessions will review specific topics, such as:

  • How to ensure success of your RWE studies and avoid pitfalls in South Korea
  • How to ensure success of your RWE studies and avoid pitfalls in Taiwan
  • How to ensure success of your RWE studies and avoid pitfalls in Spain
  • External Control Groups for Regulatory and HTA submissions
  • Multi-country RW Data Collection Studies
  • Multi-Country RW Secondary Data Studies

LEARN MORE

REGISTER TO GET UPDATES